Melody Ann Leavitt, LSCSW, ACSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 506 1/2 Main St, Mound City, KS 66056 Phone: 913-795-4414 |
News Archive
Teva Pharmaceutical Industries Ltd. and Active Biotech announced today that they have amended the marketing and distribution agreement for oral laquinimod, an investigational treatment for relapsing-remitting multiple sclerosis (RRMS). Under the new agreement, Teva extended its marketing and distribution rights to include the Nordic and Baltic regions, previously held by Active Biotech. Active Biotech will receive a higher royalty rate for sales in these territories compared to the royalty rate set under the original licensing agreement signed in 2004 for sales in the rest of the world.
In this Foreign Affairs essay, Thomas Bollyky, a senior fellow for global health, economics and development at the Council on Foreign Relations, examines the increase of non-communicable diseases (NCDs) in the developing world.
Foundation Medicine, Inc., a molecular information company that brings comprehensive cancer genome analysis to routine clinical care, today announced the initiation of a strategic collaboration with Sanofi.
In a new study led by Yale Cancer Center, researchers have discovered a novel metabolic gatekeeper mechanism for leukemia.
Researchers at the Centenary Institute in Sydney have uncovered new information about an enzyme called DPP9 that they believe to be a potential therapeutic target for limiting tumour growth and its ability to spread to and in the liver.
› Verified 1 days ago